Welcome to our dedicated page for Fmc SEC filings (Ticker: FMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The FMC Corporation (NYSE: FMC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a global agricultural sciences company focused on crop protection, biologicals, crop nutrition, and digital and precision agriculture, FMC uses its SEC reports to detail its financial condition, restructuring activities, capital structure and governance.
Investors can review current reports on Form 8-K, where FMC discloses material events such as quarterly earnings releases, leadership changes, restructuring initiatives and credit agreement amendments. For example, the company has filed 8-Ks describing quarterly financial results, the comprehensive Project Foundation cost optimization plan and Manufacturing Restructuring Program, and an amendment to its Fifth Amended and Restated Credit Agreement that adjusts leverage and interest coverage covenants and places conditions on dividends and indebtedness.
Through its periodic annual reports on Form 10-K and quarterly reports on Form 10-Q (accessible via EDGAR and summarized on this page), FMC provides more detailed information on revenue by region, cost structure, research and development spending on new herbicide, insecticide and fungicide active ingredients, and risks related to competition, regulation and restructuring. These filings also describe the company’s geographic footprint, including its headquarters in Philadelphia, Pennsylvania, and its operations across North America, Latin America, Asia and EMEA.
The filings page also highlights governance and board-related disclosures, such as 8-K reports on director resignations or executive departures, and may include proxy materials that discuss executive compensation and board composition. For those monitoring capital structure and liquidity, filings related to credit facilities, covenant changes and potential asset sales—such as the planned divestiture of the India commercial business—are particularly relevant.
Stock Titan enhances these documents with AI-powered summaries that explain key points in plain language, helping users interpret complex sections of lengthy 10-Ks, 10-Qs and 8-Ks. Real-time updates from EDGAR ensure that new filings, including any Form 4 insider transaction reports or additional restructuring disclosures, appear promptly so investors can track how FMC’s financial and strategic decisions evolve over time.
FMC Corporation (FMC) — Form 4 insider transaction: Director Carol Anthony Davidson reported a market purchase of common stock. On 11/05/2025, she bought 10,000 shares (Transaction Code P) at an average price of $13.5957 per share. Following this trade, she directly owns 23,227 shares.
This filing reflects a personal share purchase by a board member and updates her direct beneficial ownership.
FMC Corporation reported a sharp downturn for Q3 2025. Net loss attributable to stockholders was $569.3 million$542.2 million, compared with $65.0 million profit on $1,065.4 million revenue a year ago. Results were driven by actions to prepare the India commercial business for sale.
The India plan triggered approximately $510 million in total adjustments, including $419 million of revenue charges and a $226.8 million asset impairment, partially offset by a $144 million credit to cost of sales. Assets held for sale were $826.5 million; net assets were $450.0 million.
Year-to-date operating cash flow was $(663.3) million. Debt activity included issuing $750 million 8.45% Subordinated Notes and redeeming $500 million of 2026 senior notes; commercial paper rose to $981.8 million. Leverage was 4.94 versus a 5.25 maximum, and interest coverage was 3.93 versus a 3.00 minimum; the company was in covenant compliance. Common shares outstanding were 124,920,067 as of September 30, 2025.
FMC Corporation reported a leadership change, announcing that President Ronaldo Pereira will depart effective December 15, 2025. Pereira has served in various roles at FMC since 1995 and became President in 2024.
The company also furnished a press release on October 29, 2025 as Exhibit 99.1. The disclosure under Regulation FD is being furnished, not filed, under the Exchange Act.
Jacqueline Scanlan, Executive VP & Chief HRO of FMC Corporation (FMC), reported two dispositions of common stock on 09/29/2025. She sold 3,790 shares at $34.00 and 5,177 shares at $33.64, reducing her direct beneficial ownership to 27,867 shares after the transactions. The filing notes the 3,790-share sale executed automatically under a Rule 10b5-1 trading plan adopted May 16, 2025. The Form 4 was signed by an attorney-in-fact on 09/30/2025.
Form 144 notice for FMC (FMC) reports a proposed sale of 3,790 common shares through Fidelity Brokerage Services with an aggregate market value of $128,860, with an approximate sale date of 09/29/2025. The shares were acquired on 09/27/2025 by restricted stock vesting from the issuer and the payment type is listed as compensation. The filing also discloses a prior sale by Jacqueline D. Scanlan of 1,510 shares on 08/18/2025 for gross proceeds of $56,609.90. The notice includes the mandatory representation that the seller does not possess undisclosed material adverse information about the issuer.
Jacqueline Scanlan, Executive VP & Chief HRO of FMC Corporation (FMC), reported a sale of 1,510 shares of FMC common stock on 08/18/2025 at a price of $37.49 per share, reducing her beneficial ownership to 36,834 shares. The filing indicates the transaction was made pursuant to a Rule 10b5-1 plan. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Form 144 notice for FMC Corporation (FMC) reports a proposed sale of 1,510 common shares held in a brokerage account at Fidelity with an aggregate market value of $56,609.90. The shares were acquired on 09/27/2024 through restricted stock vesting as compensation, and the filer indicates an approximate sale date of 08/18/2025 on the NYSE. The filing shows 124,911,586 shares outstanding for context. No securities were reported sold by the filer in the past three months. The notice includes the standard representation that the seller has no undisclosed material adverse information.
FAQ
What is the current stock price of Fmc (FMC)?
What is the market cap of Fmc (FMC)?
